Related Experiment Video
Updated: Mar 30, 2026

06:35
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
17.4K
Ensemble Merit Merge Feature Selection for Enhanced Multinomial Classification in Alzheimer's Dementia
T R Sivapriya1, A R Nadira Banu Kamal2, P Ranjit Jeba Thangaiah3
1Department of Computer Science, Lady Doak College, Madurai, Tamil Nadu 625002, India ; The Alzheimer's Disease Neuroimaging Initiative, San Diego, CA 92093-0949, USA.
Computational and Mathematical Methods in Medicine
|November 18, 2015
Summary
This study introduces a new method for diagnosing dementia using an ensemble classifier and Merit Merge feature selection. The approach accurately distinguishes between healthy individuals and those with Mild Cognitive Impairment or Alzheimer's Dementia.
Area of Science:
- Medical Informatics
- Machine Learning
- Neuroscience
Background:
- Diagnosing dementia is complex due to large feature sets from brain imaging and neuropsychological tests.
- Objective and reliable diagnostic techniques are crucial for effective dementia care.
- Conventional classification methods struggle with high-dimensional medical data.
Purpose of the Study:
- To develop an ensemble classifier with Merit Merge feature selection for efficient multivariate multiclass medical data classification.
- To enhance the accuracy and objectivity of disease diagnostics, specifically for dementia.
- To improve upon existing classification techniques for early and reliable disease detection.
Main Methods:
- Utilized an ensemble approach trained with features selected from multiple biomarkers.
- Employed Particle Swarm Optimization for feature subset retrieval.
- Experimented with classifiers including Naïve Bayes, Random Forest, Support Vector Machine, and C4.5.
- Integrated the C4.5 ensemble classifier with Particle Swarm Optimization search and Merit Merge technique (CPEMM).
Main Results:
- The proposed CPEMM feature selection method outperformed bagging feature selection across SVM, NB, and Random Forest classifiers.
- CPEMM identified an optimal feature subset for discriminating between normal individuals and patients with Mild Cognitive Impairment and Alzheimer's Dementia.
- Achieved a classification accuracy of 98.7% in distinguishing between healthy individuals and dementia patients.
Conclusions:
- The developed ensemble classifier with Merit Merge feature selection (CPEMM) significantly enhances classification efficiency and accuracy in medical data.
- This method offers a more objective and reliable approach to dementia diagnostics.
- The findings suggest a promising tool for early and accurate detection of Mild Cognitive Impairment and Alzheimer's Dementia.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

